© Copyright Nostre Net
Market Overview
The global autoimmune disease treatment market size is
expected to balloon at 11.2% CAGR from 2017 to 2023 (forecast period). High
prevalence of autoimmune disorders is one of the primary drivers of the market.
This is supported by the survey by the National Institute of Health (NIH) which
pegs the number of Americans suffering from autoimmune diseases at 23.5
million. The growing public awareness levels as well as the large efforts taken
by government healthcare organizations for curbing the menace of these diseases
can bode well for the market.
The centralization of patient response to novel drugs and
treatments on a common database is likely to expedite the progress of
autoimmune drugs exponentially. Technological advances, rising prevalence of
comorbidities, rise of regulatory frameworks, and rise of government supported
networks are other growth drivers of the market.
But presence of unbranded drugs, side-effects of
medications, and high treatment costs are challenges faced by the global autoimmune
disease treatment market.
Get Sample Report @https://www.marketresearchfuture.com/sample_request/5586
Competition Outlook
Johnson & Johnson Inc., Danaher, Siemens, Bio-Rad, Merck
& Co. Inc., Genentech Inc., Biogen Idec Inc., F. Hoffmann-La Roche AG, Eli
Lilly and Company, Thermo Fisher Scientific, Abbott Laboratories, HYCOR
Biomedical, Squibb Company, Bayer Schering Pharma AG, Elan Corporation Plc,
GlaxoSmithKline Plc, Chugai Pharmaceutical Co. Ltd., Amgen Inc., and others are
major players in the global autoimmune disease treatment market.
Segmentation
The global autoimmune disease treatment market is segmented
on the basis of disease type, diagnosis, therapeutic product, and distribution
channel.
By disease type, the market is segmented into systemic and
localized. Systemic is further segmented into psoriasis, lupus, rheumatoid
arthritis, and others. Localized, on the other hand, is segmented into
diabetes, inflammatory bowel disease, and others.
By diagnosis, the autoimmune disease treatment market is
segmented into multiplex immunoassay, agglutination, dot blot, line blot,
ELISA, double immune diffusion, Western blotting, and others.
By therapeutic product, it is segmented into drugs and
therapeutic & monitoring equipment. Corticosteroids, immunosuppressants,
biologics, anti-inflammatory drugs, and non-steroidal anti-inflammatory drugs
are segments subsumed within the drugs segment.
By distribution channel, it is segmented into pharmacies,
drug stores, hospitals & clinics, diagnostic centers, and others.
Regional Analysis
The Middle East & Africa (MEA), Europe, Asia Pacific
(APAC), and the Americas are regions taken into consideration during the
compilation of the global autoimmune disease treatment market report.
The Americas are touted to dominate in the leading position
during the forecast period due to a large healthcare expenditure and increase
in the cases of autoimmune diseases. Introduction of favorable healthcare
policies such as the Affordable Care Act and efforts by the American Autoimmune
Related Diseases Association (AARDA) are likely to culminate in high dividends
for the autoimmune disease treatment market from the region.
Europe is the second largest region with the biggest
potential for the global market. Factors such as healthcare policies,
introduction of autoimmune diagnostic techniques, and allocation of sufficient
funds by governments can drive the regional demand.
The APAC region is expected to exhibit a robust growth rate
during the forecast period due to the healthcare budget being elevated in
several countries. The large patient pool as well as the rising number of
medicines being developed at pharmaceutical companies can contribute to the
market revenue.
The MEA autoimmune disease treatment market possesses the
lowest potential for returns due to poor healthcare infrastructure and lack of
technical experts.
Access full report @ https://www.marketresearchfuture.com/reports/autoimmune-disease-treatment-market-5586
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
The Wall